000154767 001__ 154767
000154767 005__ 20240229120024.0
000154767 0247_ $$2doi$$a10.1016/j.cellimm.2017.10.013
000154767 0247_ $$2pmid$$apmid:29129292
000154767 0247_ $$2ISSN$$a0008-8749
000154767 0247_ $$2ISSN$$a1090-2163
000154767 0247_ $$2altmetric$$aaltmetric:79972033
000154767 037__ $$aDKFZ-2020-01014
000154767 041__ $$aeng
000154767 082__ $$a610
000154767 1001_ $$aSchupp, Jonathan$$b0
000154767 245__ $$aTargeting myeloid cells in the tumor sustaining microenvironment.
000154767 260__ $$aAmsterdam [u.a.]$$bElsevier$$c2019
000154767 3367_ $$2DRIVER$$aarticle
000154767 3367_ $$2DataCite$$aOutput Types/Journal article
000154767 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1589283740_32506$$xReview Article
000154767 3367_ $$2BibTeX$$aARTICLE
000154767 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154767 3367_ $$00$$2EndNote$$aJournal Article
000154767 520__ $$aMyeloid cells are the most abundant cells in the tumor microenvironment (TME). The tumor recruits and modulates endogenous myeloid cells to tumor-associated macrophages (TAM), dendritic cells (DC), myeloid-derived suppressor cells (MDSC) and neutrophils (TAN), to sustain an immunosuppressive environment. Pathologically overexpressed mediators produced by cancer cells like granulocyte-macrophage colony-stimulating- and vascular endothelial growth factor induce myelopoiesis in the bone marrow. Excess of myeloid cells in the blood, periphery and tumor has been associated with tumor burden. In cancer, myeloid cells are kept at an immature state of differentiation to be diverted to an immunosuppressive phenotype. Here, we review human myeloid cells in the TME and the mechanisms for sustaining the hallmarks of cancer. Simultaneously, we provide an introduction into current and novel therapeutic approaches to redirect myeloid cells from a cancer promoting to a rather inflammatory, cancer inhibiting phenotype. In addition, the role of platelets for tumor promotion is discussed.
000154767 536__ $$0G:(DE-HGF)POF3-899$$a899 - ohne Topic (POF3-899)$$cPOF3-899$$fPOF III$$x0
000154767 588__ $$aDataset connected to CrossRef, PubMed,
000154767 7001_ $$0P:(DE-He78)41a3eb2e61458591611a88a36b66a5f3$$aKrebs, Franziska$$b1
000154767 7001_ $$aZimmer, Niklas$$b2
000154767 7001_ $$aTrzeciak, Emily$$b3
000154767 7001_ $$aSchuppan, Detlef$$b4
000154767 7001_ $$aTuettenberg, Andrea$$b5
000154767 773__ $$0PERI:(DE-600)1462601-9$$a10.1016/j.cellimm.2017.10.013$$gVol. 343, p. 103713 -$$p103713$$tCellular immunology$$v343$$x0008-8749$$y2019
000154767 909CO $$ooai:inrepo02.dkfz.de:154767$$pVDB
000154767 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz
000154767 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCELL IMMUNOL : 2017
000154767 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154767 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154767 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000154767 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000154767 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000154767 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000154767 915__ $$0StatID:(DE-HGF)0110$$2StatID$$aWoS$$bScience Citation Index
000154767 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154767 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154767 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences
000154767 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews
000154767 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000154767 9141_ $$y2019
000154767 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)41a3eb2e61458591611a88a36b66a5f3$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000154767 9131_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000154767 9201_ $$0I:(DE-He78)L501-20160331$$kL501$$lDKTK Frankfurt$$x0
000154767 980__ $$ajournal
000154767 980__ $$aVDB
000154767 980__ $$aI:(DE-He78)L501-20160331
000154767 980__ $$aUNRESTRICTED